"É um espaço único na área da saúde na Europa, que foca a sua intervenção no tratamento, reabilitação e investigação de doenças neurológicas."

During the past decade, Campus Neurologico Senior conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Campus Neurologico Senior" #1 sponsor was "Campus Neurológico Sénior" with 3 trials, followed by "Theravance Biopharma" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Biogen" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Campus Neurologico Senior" #1 collaborator was "University of Lisbon" with 2 trials as a collaborator and "Johns Hopkins University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Campus Neurologico Senior" are "Symptomatic Neurogenic Orthostatic Hypotension" (3 trials), "Alzheimer's Disease" (2 trials), "Multiple Sclerosis" (2 trials), "Parkinson Disease" (2 trials) and "MSA" (1 trials). Many other conditions were trialed in "Campus Neurologico Senior" in a lesser frequency.

Most popular intervention types in "Campus Neurologico Senior" are "Drug" (11 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "ampreloxetine" (3 trials), "AHA Exergame System" (1 trials), "Aducanumab" (1 trials) and "Aducanumab (BIIB037)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Campus Neurologico Senior" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Campus Neurologico Senior". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Campus Neurologico Senior, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Campus Neurologico Senior, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".